193 related articles for article (PubMed ID: 33142910)
1. Histamine H
Kawashima R; Tamaki S; Kawakami F; Maekawa T; Ichikawa T
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33142910
[TBL] [Abstract][Full Text] [Related]
2. Exacerbation of nonsteroidal anti-inflammatory drug-induced small intestinal lesions by antisecretory drugs in rats: the role of intestinal motility.
Satoh H; Amagase K; Takeuchi K
J Pharmacol Exp Ther; 2012 Nov; 343(2):270-7. PubMed ID: 22854201
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive time course and correlation analysis of indomethacin-induced inflammation, bile acid alterations and dysbiosis in the rat small intestine.
Lázár B; László SB; Hutka B; Tóth AS; Mohammadzadeh A; Berekméri E; Ágg B; Balogh M; Sajtos V; Király K; Al-Khrasani M; Földes A; Varga G; Makra N; Ostorházi E; Szabó D; Ligeti B; Kemény Á; Helyes Z; Ferdinandy P; Gyires K; Zádori ZS
Biochem Pharmacol; 2021 Aug; 190():114590. PubMed ID: 33940029
[TBL] [Abstract][Full Text] [Related]
4. Effect of a new non-steroidal anti-inflammatory combination of a histamine H2 antagonist and indomethacin on gastroduodenal mucosal membrane in rat.
Segawa Y; Omata T; Abe T; Tsuzuike N; Itokazu Y; Yoshida K; Ueda I
Arzneimittelforschung; 1992 Oct; 42(10):1232-5. PubMed ID: 1361736
[TBL] [Abstract][Full Text] [Related]
5. The microbiota-derived metabolite indole decreases mucosal inflammation and injury in a murine model of NSAID enteropathy.
Whitfield-Cargile CM; Cohen ND; Chapkin RS; Weeks BR; Davidson LA; Goldsby JS; Hunt CL; Steinmeyer SH; Menon R; Suchodolski JS; Jayaraman A; Alaniz RC
Gut Microbes; 2016 May; 7(3):246-61. PubMed ID: 27007819
[TBL] [Abstract][Full Text] [Related]
6. Dosage effects of histamine-2 receptor antagonist on the primary prophylaxis of non-steroidal anti-inflammatory drug (NSAID)-associated peptic ulcers: a retrospective cohort study.
He Y; Chan EW; Man KK; Lau WC; Leung WK; Ho LM; Wong IC
Drug Saf; 2014 Sep; 37(9):711-21. PubMed ID: 25096957
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of roxatidine against indomethacin-induced small intestinal mucosal injury in rats.
Umegaki E; Yoda Y; Tokioka S; Murano M; Higuchi K
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S35-40. PubMed ID: 20586863
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
Rainsford KD; Stetsko PI; Sirko SP; Debski S
J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
[TBL] [Abstract][Full Text] [Related]
9. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
;
Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333
[TBL] [Abstract][Full Text] [Related]
10. Prevention of gastric ulcer relapse induced by indomethacin in rats by a mutein of basic fibroblast growth factor.
Satoh H; Asano S; Maeda R; Murakami I; Inada I; Sato F; Shino A
Jpn J Pharmacol; 1997 Mar; 73(3):229-41. PubMed ID: 9127818
[TBL] [Abstract][Full Text] [Related]
11. High-fat diet-mediated dysbiosis exacerbates NSAID-induced small intestinal damage through the induction of interleukin-17A.
Sugimura N; Otani K; Watanabe T; Nakatsu G; Shimada S; Fujimoto K; Nadatani Y; Hosomi S; Tanaka F; Kamata N; Taira K; Nagami Y; Tanigawa T; Uematsu S; Fujiwara Y
Sci Rep; 2019 Nov; 9(1):16796. PubMed ID: 31727909
[TBL] [Abstract][Full Text] [Related]
12. Effect of epidermal growth factor on non-steroidal anti-inflammatory drug-induced intestinal damage.
DiJoseph JF; Wells CL
Agents Actions; 1989 Jun; 27(3-4):294-6. PubMed ID: 2572161
[TBL] [Abstract][Full Text] [Related]
13. Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine.
Miyake K; Ueki N; Suzuki K; Shinji Y; Kusunoki M; Hiratsuka T; Nishigaki H; Tatsuguchi A; Futagami S; Wada K; Tsukui T; Nakajima A; Yoshino S; Sakamoto C
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():67-72. PubMed ID: 15943850
[TBL] [Abstract][Full Text] [Related]
14. Revaprazan prevented indomethacin-induced intestinal damages by enhancing tight junction related mechanisms.
Han YM; Park JM; Her S; Kim MS; Park YJ; Hahm KB
Biochem Pharmacol; 2020 Dec; 182():114290. PubMed ID: 33075311
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effect of an omega-6 PUFA-rich diet in non-steroidal anti-inflammatory drug-induced mucosal damage in the murine small intestine.
Ueda T; Hokari R; Higashiyama M; Yasutake Y; Maruta K; Kurihara C; Tomita K; Komoto S; Okada Y; Watanabe C; Usui S; Nagao S; Miura S
World J Gastroenterol; 2015 Jan; 21(1):177-86. PubMed ID: 25574090
[TBL] [Abstract][Full Text] [Related]
16. Mucosal protection by H2 antagonists against injury by non-steroidal anti-inflammatory agents.
Giercksky KE
Scand J Gastroenterol Suppl; 1989; 163():32-5. PubMed ID: 2573146
[TBL] [Abstract][Full Text] [Related]
17. Lafutidine Ameliorates Indomethacin-Induced Small Intestinal Damage in Rats by Modifying the Intestinal Mucosal Barrier, Inflammation, and Microbiota.
Zhu L; Guo J; Liu Q; Luo Y; Zhao J; Zhong W; Sun S; Xu X; Liang H; Lou C; Song C; Chen J; Zhao J; Wang B; Chen X
Pharmacology; 2023; 108(3):286-300. PubMed ID: 37023725
[TBL] [Abstract][Full Text] [Related]
18. Effects of esomeprazole on healing of nonsteroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: Characterization of molecular mechanisms.
Fornai M; Colucci R; Antonioli L; Awwad O; Ugolini C; Tuccori M; Fulceri F; Natale G; Basolo F; Blandizzi C
Pharmacol Res; 2011 Jan; 63(1):59-67. PubMed ID: 20969958
[TBL] [Abstract][Full Text] [Related]
19. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds.
Scarpignato C; Pelosini I
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S63-72. PubMed ID: 10379472
[TBL] [Abstract][Full Text] [Related]
20. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
